ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Down 10.7% – Here’s What Happened

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) fell 10.7% during trading on Tuesday. The stock traded as low as $15.96 and last traded at $15.96. 54,431 shares were traded during trading, a decline of 76% from the average session volume of 226,006 shares. The stock had previously closed at $17.88.

Wall Street Analyst Weigh In

CHRN has been the subject of a number of recent research reports. Northland Securities assumed coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, September 18th. They issued an “outperform” rating and a $32.00 price objective for the company. Weiss Ratings raised shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, ChronoScale Corporation Common Stock currently has a consensus rating of “Hold” and a consensus price target of $19.00.

ChronoScale Corporation Common Stock Stock Down 10.3%

The firm has a market cap of $2.33 billion, a PE ratio of -2.98 and a beta of 0.98. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.51 and a current ratio of 0.51. The company’s 50-day simple moving average is $20.31 and its two-hundred day simple moving average is $18.08.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%. The firm had revenue of $18.40 million during the quarter.

Institutional Trading of ChronoScale Corporation Common Stock

An institutional investor recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc increased its holdings in ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned approximately 0.07% of ChronoScale Corporation Common Stock worth $25,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 6.42% of the stock is currently owned by institutional investors and hedge funds.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.